Susceptibility-weighted imaging (SWI) has been widely used in clinical contexts, in which the speed of acquisition is frequently a critical issue. In this study, we aim to test the feasibility of a deep learning (DL)-based reconstruction method for accelerating SWI acquisition in clinical settings. A total of 61 subjects were consecutively enrolled. SWI scans using prospective under-sampling and DL-based reconstruction method (acceleration factor = 5, acquisition time: 1:46) and parallel imaging (PI, acceleration factor = 2, acquisition time: 4:45) were acquired from each subject. The DL-based method utilizes a cascaded convolutional neural network, namely, ReconNet3D, to perform k-space to image reconstruction with the capacity of single-channel input and single-channel output. The DL-SWI and PI-SWI results were compared quantitatively using structural similarity index (SSIM) and peak signal-to-noise ratio (PSNR). Two raters independently assessed image quality from five aspects: artifacts, noise level, sharpness, lesion conspicuity, and overall image quality. The numbers of microbleeds were also counted. Finally, both sets of images of the same subject were reviewed side-by-side for noninferiority assessments. The DL-SWI images showed good similarity in terms of SSIM (mean ± SD: 0.89 ± 0.02) and PSNR (mean ± SD: 36.91 ± 2.41) with PI-SWI. In comparison, DL-SWI images had significantly better scores in terms of artifacts, noise, and overall image quality score (4.15 vs. 3.33; 3.85 vs. 3.16; 3.85 vs. 3.44, all with p < 0.001). DL-SWI showed reduced image sharpness (p = 0.031), but no significant difference regarding lesion conspicuity. The number of microbleeds identified from the DL-SWI images completely matched the PI-SWI results. We had not observed any false-negative or false-positive readings on DL-SWI images. The DL-based SWI acceleration method could significantly reduce scan time and maintain image quality, suggesting its great potential in clinical applications.

Download full-text PDF

Source
http://dx.doi.org/10.1002/nbm.5320DOI Listing

Publication Analysis

Top Keywords

image quality
12
method accelerating
8
susceptibility-weighted imaging
8
clinical settings
8
dl-based reconstruction
8
reconstruction method
8
acquisition time
8
artifacts noise
8
dl-swi images
8
validation deep
4

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

Eisai Inc., Nutley, NJ, USA.

Lecanemab, a humanized IgG1 monoclonal antibody that binds with high affinity to amyloid-beta (Aβ) protofibrils, was formally evaluated as a treatment for early Alzheimer's disease in a phase 2 study (Study 201) and the phase 3 Clarity AD study. These trials both included an 18-month, randomized study (core) and an open-label extension (OLE) phase where eligible participants received open-label lecanemab for up to 30 months to date. Clinical (CDR-SB, ADAS-Cog14, and ADCS-MCI-ADL), biomarker (PET, Aβ42/40 ratio, and ptau181) and safety outcomes were evaluated.

View Article and Find Full Text PDF

Background: The Sino-nasal Outcome Test (SNOT-22) is a 22-question survey that is utilized to evaluate health-related quality of life of patients with chronic rhinosinusitis (CRS). The Patient Global Impression Symptom Severity (PGISS) is a similar yet versatile instrument that combines features of both a Likert scale and a visual analog to assess symptom severity in CRS patients. While previous studies have evaluated the validity of SNOT-22 as an instrument to measure CRS patients' symptom severity, no studies have evaluated PGISS scale's ability to evaluate and guide treatment plans for CRS patients.

View Article and Find Full Text PDF

Background: This study explores Alzheimer's prediction through brain MRI images, utilizing Convolutional Neural Networks (CNNs) and Lime interpretability. Based on an extensive ADNI MRI dataset, we demonstrate promising results in predicting Alzheimer's disease. Local Interpretable Model Agnostic Explanations (LIME) shed light on decision-making processes, enhancing transparency.

View Article and Find Full Text PDF

Dementia Care Research and Psychosocial Factors.

Alzheimers Dement

December 2024

Prevent Alzheimer's Disease 2020, Inc., Rockville, MD, USA.

Background: Disparities in the quality and timeliness of care for Alzheimer's disease (AD) are well documented. This study assessed the impact of demographic characteristics on the diagnosis and management of early AD patients in community-based settings.

Method: This cross-sectional study abstracted medical chart data for patients aged 50-89 years who had newly diagnosed early AD (mild cognitive impairment [MCI] or mild AD) within the past 2 years and a clinic visit within the past 12 months.

View Article and Find Full Text PDF

Background: Luminal and hemodynamic evaluations of the cervical arteries inform the diagnosis and management of patients with cervical arterial disease.

Purpose: To demonstrate a 3D nonenhanced quantitative quiescent interval slice-selective (qQISS) magnetic resonance angiographic (MRA) strategy that provides simultaneous hemodynamic and luminal evaluation of the cervical arteries.

Study Type: Prospective.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!